International Journal of Hematology

Article	Citations
Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation	56
Obituary of Professor Fumimaro Takaku: a tribute to a real leader in medicine in Japan (1931–2022)	44
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan	37
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008–2020	36
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis	32
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)	24
Honeycomb lung appearance accompanied by pediatric Langerhans cell histiocytosis: changes in imaging findings following chemotherapy	23
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia	23
Anakinra for the treatment of adult secondary HLH: a retrospective experience	19
Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study	19
Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review	18
Bilateral adrenal hemorrhage: a rare presentation of acute myeloid leukemia	18
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	17
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide	17
Conditioning regimens for inborn errors of immunity: current perspectives and future strategies	17
Human leukocyte antigen 7/8-matched unrelated bone marrow transplantation using anti-thymocyte globulin in children	16
Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance	16
Impact of stem cell source on secondary steroid for chronic GVHD after allogeneic hematopoietic cell transplantation	15
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	15
A case of multiple brain abscesses due to Bacillus cereus during induction therapy for acute myeloid leukemia	14
Bringing mass spectrometry into the care of patients with multiple myeloma	14
A case of neurodegenerative Langerhans cell histiocytosis exhibiting high osteopontin in cerebrospinal fluid without specific radiological abnormalities	14
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	14
Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML	13
Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation	13

Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	13
Chronic neutrophilic leukemia preceded by myelodysplastic syndromes	13
High-dose dexamethasone as the first-line treatment in children with primary immune thrombocytopenia?	12
Unilateral recurrent laryngeal nerve palsy detected by PET/CT in a patient with mediastinal T-cell lymphoblastic lymphoma	12
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease	12
Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population	12
Stem cell regulation and dynamics in myeloid malignancies	12
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study	11
Clinical guidelines for prevention and treatment of CAT in Japan and other countries	11
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment	11
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	11
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia	11
First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes	10
Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors	10
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	10
Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden	10
Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study	10
Lethal macrophage-related complications of juvenile myelomonocytic leukemia with a blastic crisis: an autopsy case report	10
Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort study	10
Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan	10
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	10
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantation	10
Clinical characteristics of steroid-responsive but dependent chronic graft-versus-host disease: a multicenter retrospective analysis	10
Bosutinib-induced lung injury: a report of two cases and literature review	10
A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT	10
Risk factors for unplanned removal of central venous catheters in hospitalized children with hematological and oncological disorders	9
Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice	9
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	9
Treatment options and pregnancy management for patients with PV and ET	9
A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor	9
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors	8
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial	8
EBV-PTLD in a patient after haploidentical stem-cell transplantation with post-transplant cyclophosphamide	8
Reply to the Dr. Murphy’s comment	8
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	8
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial)	8
Factor XII deficiency: a clinical and molecular genetic study	8
Acquired hypofibrinogenemia in a patient with multiple myeloma	8
Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment	8
Post-transfusion purpura and adult primary thrombocytopenia	8
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	8
Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review	8
Age and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia	8
Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes	7
Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report	7
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL	7
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	7
Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin infant mimicking aleukemic leukemia cutis	7
Protection from bleeds during physical activity in people with haemophilia: the role of factor levels: a response to Nogami et al. (2023)	7
A review of the Augustine blood group system	7

Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia	7
High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder	7
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	7
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	7
Biological and clinical significance of epigenetic alterations in B-cell lymphomas	7
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	7
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan	7
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia	7
Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients	7
Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report	7
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	7
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation	7
Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases	7
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	7
Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII	6
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance	6
Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia	6
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	6
Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collection	6
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	6
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia	6
In memory of Prof. Minoru Okuma	6
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	6
Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases	6
A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation	6
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody	6
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	6
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	6
Light chain proximal tubulopathy diagnosed solely by electron microscopy of a renal biopsy specimen in a patient with monoclonal gammopathy of undetermined significance	6
Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide	6
Nutritional status and quality of life in adults undergoing allogeneic hematopoietic stem cell transplantation	6
Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis	6
T cell lymphoma: time to make discoveries and advance treatment	6
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia	6
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	6
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect	6
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	6
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	6
GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1	6
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	6
Hematopoietic cell transplantation for mantle cell lymphoma	6
Cancer-associated thrombosis in hematologic malignancies	5
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	5
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	5
Severe systemic inflammation mimicking TAFRO syndrome following COVID-19	5
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study	5
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	5
Drug interaction between letermovir and voriconazole after allogeneic hematopoietic cell transplantation	5
Antibody response to COVID-19 vaccination in patients with lymphoma	5
Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care	5
Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis	5
Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia	5
Cancer-associated thrombosis and bleeding	5
JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	5
Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	5
Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era	5
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation	5
Validation of an analytical method for the quantification of human fibrinogen in pharmaceutical products by size-exclusion liquid chromatography (SEC-HPLC)	5
Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia	5
Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation	5
Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan	5
Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan	5
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	5
Carcinocythemia diagnosed on peripheral blood clot sections	5
Correction: Moving towards biologically informed treatment strategies for T-cell lymphomas	5
Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia	5
Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation	5
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report	5
Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience	5
Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation	4
Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression	4
Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation	4
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma	4
Effectiveness of venetoclax and azacytidine against myeloid/natural killer cell precursor acute leukemia	4
Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies	4
Expression of activated integrin β7 in multiple myeloma patients	4
Rivaroxaban for severe superior sagittal sinus thrombosis in a child with ALL	4
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	4
Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation	4
Frequency and driver mutation diversity of concomitant chronic myeloid leukemia and Philadelphia chromosome-negative myeloproliferative neoplasm	4

ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial	4
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	4
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM	4
The Nup98::Nsd1 fusion gene induces CD123 expression in 32D cells	4
Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment	4
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	4
Diagnosis of immune pathophysiology in patients with bone marrow failure	4
Multifocal osteonecrosis after stem cell transplantation	4
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma	4
Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation	4
Isolated thrombosis after COVID-19 vaccination: case series	4
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	4
Simultaneous diagnosis of plasma cell myeloma and chronic lymphocytic leukemia on bone marrow trephine biopsy	4
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma	4
Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review	4
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	4
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis	4
Increasing numbers of CD19 + CD24highCD38high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune	4
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	4
Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet	4
Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02	4
Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients	4
Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature	4
Clostridium septicum myonecrosis following chemotherapy	4
Practical management of patients with hematological diseases during the COVID-19 pandemic in Japan	4
Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome	4
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	4
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	4
Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation	4
Cytomegalovirus-induced stomatitis in a patient with refractory diffuse large B-cell lymphoma	4
Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a lite	4
Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival	4
Development of CMV-CD19 bi-specific CAR T cells with post-infusion in vivo boost using an anti-CMV vaccine	3
Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial	3
Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial	3
High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials	3
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	3
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study	3
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	3
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	3
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	3
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	3
JSH practical guidelines for hematological malignancies, 2023: leukemia-6. Myelodysplastic syndromes (MDS)	3
ETV6-related thrombocytopenia associated with a transient decrease in von Willebrand factor	3
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence	3
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum	3
Association of depression and social anxiety symptom scores with disease characteristics in pediatric patients with chronic immune thrombocytopenia: a cross-sectional study	3
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia	3
Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases	3
The pathogenesis of cancer-associated thrombosis	3
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	3
Novel treatment strategies for hematological malignancies in the immunotherapy era	3
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	3
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	3
Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth	3
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	3
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation	3
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen	3
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease	3
Early chemotherapeutic intervention to avoid thyroidectomy in pediatric Langerhans cell histiocytosis with thyroid involvement accompanying tracheal stenosis: a report of two cases	3
Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic/early primary myelofibrosis	3
Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in c	3
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	3
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial	3
Mycobacterial lymphadenitis without granuloma formation in a patient with anti-interferon-gamma antibodies	3
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial	3
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	3
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia	3
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva	3
C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis	3
Identification of a novel mutation in the factor XIII A subunit in a patient with inherited factor XIII deficiency	3
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation	3
Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II	3
Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome	3
Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases	3
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitors	3
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome	3
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective stud	3
Fetal hemoglobin level predicts lower-risk myelodysplastic syndrome	3
Guest editorial: current status and future perspectives of allogeneic hematopoietic cell transplantation for non-malignant diseases	3
Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine	3